Target intelligence / Profile preview

CLVS1 antisense RNA 1 (CLVS1-AS1)

Target
CLVS1-AS1
Molecular classification
Other (non-coding RNA)
01

Overview

CLVS1 antisense RNA 1 (CLVS1-AS1) is a human gene transcribing a long non-coding RNA (lncRNA)[1][7]. This transcript is located antisense to the CLVS1 gene, but there are currently no well-established biological functions, disease associations, or therapeutic relevance documented in the literature or gene annotation databases[1][7]. The gene is catalogued as a non-protein-coding RNA, and existing resources do not link CLVS1-AS1 to any pathway, protein product, or clinical biomarker utility[1][7]. Due to the lack of supporting evidence for a role in human disease or viability as a drug target, CLVS1-AS1 is not considered a therapeutic target. The designation "is_incorrect: true" reflects the fact that this is not a target molecule in the sense of a druggable protein, receptor, or enzyme; it is a non-coding RNA with no current evidence of clinical or experimental targeting utility[1][7]. *Note: No evidence was found for aliases, function, disease involvement, drug interaction, mechanism of action, biomarker status, or safety considerations. If you intended to refer to the protein-coding gene CLVS1 (clavesin-1), that is a separate entity with biological function and associated literature[2][9].*

Beyond the preview

Go deeper on CLVS1 antisense RNA 1 (CLVS1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CLVS1 antisense RNA 1 (CLVS1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call